COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 2730: Articles 27291-27300  | Next

COVID-19; Systematic and literature review of transmission, case definitions, clinical management and clinical trials.
McArthur, L., Sakthivel, D., Ataide, R., Chan, F., Richards, J. S., Narh, C. A.
10.1101/2020.05.14.20102475 — Posted: 2020-05-20
Who is lonely in lockdown? Cross-cohort analyses of predictors of loneliness before and during the COVID-19 pandemic
Bu, F., Steptoe, A., Fancourt, D.
10.1101/2020.05.14.20101360 — Posted: 2020-05-20
Risk interactions of coronavirus infection across age groups after the peak of COVID-19 epidemic
Yu, X.
10.1101/2020.05.17.20105049 — Posted: 2020-05-19
Clinical evaluation of IFN beta1b in COVID-19 pneumonia: a retrospective study
Estebanez, M., Martinez-Oliveira, G., Mata, T., Marti, D., Gutierrez, C., De Dios, B., Dolores Herrero, M., Roel, A., Martinez, Y., Aguirre, A., Alcantara Nicolas, F., Fernandez Gonzalez, P., Lopez, E., Ballester, L. E., Mateo-Maestre, M., Campos, S., Sanchez-Carrillo, M. J., Fe, A., Membrillo de Novales, F. J.
10.1101/2020.05.15.20084293 — Posted: 2020-05-19
Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2
Mick, E., Kamm, J., Pisco, A. O., Ratnasiri, K., Babik, J. M., Calfee, C. S., Castaneda, G., DeRisi, J. L., Detweiler, A., Hao, S., Kangerlaris, K. N., Kumar, G. R., Li, L. M., Mann, S. A., Neff, N., Prasad, P. A., Serpa, P. H., Shah, S. J., Spottiswoode, N., Tan, M., Christenson, S. A., Kistler, A., Langelier, C.
10.1101/2020.05.18.20105171 — Posted: 2020-05-19 Discussion: Onsite | Offsite
Empirical Assessment of COVID-19 Crisis Standards of Care Guidelines
Jezmir, J. L., Bharadwaj, M., Kishore, S. P., Winkler, M., Diephuis, B., Kim, E. Y., Feldman, W. B.
10.1101/2020.05.16.20098657 — Posted: 2020-05-19
Reciprocal association between participation to a national election and the epidemic spread of COVID-19 in France: nationwide observational and dynamic modeling study.
Zeitoun, J.-D., Faron, M., Manternach, s., Fourquet, J., Lavielle, M., lefevre, j.
10.1101/2020.05.14.20090100 — Posted: 2020-05-19
Human IgG cell neutralizing monoclonal antibodies block SARS-CoV-2 infection
Lan, F., Xu, J., Lu, Y., Wan, J., Xing, S., Wang, Y., Ding, L., Yuan, S., Qiu, C., Zhao, C., Zhang, X., Wang, X.
10.1101/2020.05.19.104117 — Posted: 2020-05-19 Discussion: Onsite
Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate
Arora, K., Rastogi, R., Arora, N. M., Parashar, D., Paliwal, J., Naqvi, A., Srivastava, A., Singh, S. K., Kalyanaraman, S., Potdar, S., Kumar, D., Arya, V. B., Bansal, S., Rautray, S., Singh, I., Fengade, P. S., Kumar, B., Kundu, P. K.
10.1101/2020.05.18.099234 — Posted: 2020-05-19
Antiviral activity of Glucosylceramide synthase inhibitors against SARS-CoV-2 and other RNA virus infections
Vitner, E. B., Avraham, R., Achdout, H., Tamir, H., Agami, A., Cherry, L., Yahalom-Ronen, Y., Politi, B., Erez, N., Melamed, S., Paran, N., Israely, T.
10.1101/2020.05.18.103283 — Posted: 2020-05-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).